Clin2
NCT07824817Possibly a fitRecruiting

Sedation options for electroconvulsive therapy

Hemodynamic Response

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study compares two medicines used during electroconvulsive therapy (ECT) to see which one causes fewer side effects and works better. ECT is a treatment for certain mental health conditions that uses electrical stimulation to the brain while you are asleep.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
24 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old
  • You are scheduled to have six ECT sessions for a psychiatric condition
  • You are generally healthy (classified as ASA I or II by your anesthesiologist)
  • You are not pregnant
  • You do not have asthma or certain heart conditions, and have not had a heart attack in the last 6 months
  • You are not currently taking beta-blocker medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07247968Recruiting· Early Phase 1
Esketamine with ECT for severe depression in teens

This study tests whether adding a low dose of esketamine (a type of anesthesia) to modified electroconvulsive therapy (ECT) helps treat severe depression in teenagers. It aims to see if this combination works better and is safer than ECT alone.

Chongqing
NCT03272698Recruiting· Phase 4
Ketamine plus ECT versus higher-dose ketamine with rescue

This study compares two ways of using ketamine with ECT (electroconvulsive therapy) in people with treatment-resistant depression. It aims to find whether a higher-dose ketamine approach, with extra rescue measures, works better or more safely.

Saskatoon, Saskatchewan
NCT07561307Not yet recruiting
Optimizing electroconvulsive therapy settings

This study looks at how to best set the electrical stimulation for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. The goal is to improve how well ECT works while possibly reducing side effects.

Philadelphia, Pennsylvania
NCT07088380Recruiting· Phase 3
Ketamine combined with ECT for hard-to-treat depression

This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.

Milan
NCT06034821Enrolling by invitation· Phase 4
ECT vs. ketamine for suicidal depression in adults

This trial compares two treatments—ECT (electroconvulsive therapy, which uses electrical stimulation) and ketamine (a medicine given as a shot)—to see which works better for quickly reducing suicidal depression. It is for adults who are in a severe depressive episode with active suicidal thoughts.

San Francisco, California
NCT06281977Recruiting· Phase 3
Dexmedetomidine for electrical storm in the ICU

This trial tests if a medication called dexmedetomidine (a sedative that can also stabilize heart rhythm) helps calm electrical storms—dangerous, repeated episodes of fast heartbeats. It is for people in the intensive care unit who are experiencing this emergency.

Rochester, Minnesota

Hear when a new Hemodynamic Response trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.